Key result
Transcatheter edge-to-edge repair has emerged as a feasible and safe alternative treatment for patients with severe tricuspid regurgitation and prohibitive operative risk.
Why the study?
Most patients with moderate-to-severe TR are treated conservatively due to high surgical risk, prompting percutaneous edge-to-edge repair as an alternative.
This review provides an overview of the current evidence and clinical results regarding transcatheter edge-to-edge repair for severe tricuspid regurgitation in patients with prohibitive operative risk.
May support TEER consideration in prohibitive-risk severe TR; leaves open randomized confirmation of benefit.
Despite the increasing knowledge of the long-term adverse consequence of severe tricuspid regurgitation (TR), most patients with moderate- to-severe TR are still treated conservatively because of the high risk of surgery. Percutaneous procedures have emerged as an attractive alternative treatment. Transcatheter edge-to-edge repair is a validated technique to treat mitral regurgitation. In recent years, the same concept has been applied to patients with TR and prohibitive operative risk. Early trials have shown feasibility and safety. More clinical experiences and long-term results are still being gathered. In this article, we provide an overview of transcatheter edge-to-edge repair and look at the current evidence and clinical results regarding procedure.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2019) conducted a review in Severe tricuspid regurgitation. Transcatheter edge-to-edge repair was evaluated. Transcatheter edge-to-edge repair has emerged as a feasible and safe alternative treatment for patients with severe tricuspid regurgitation and prohibitive operative risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: